HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in mice.

Abstract
To develop a therapeutic vaccine against hepatitis B virus surface antigen (HBsAg)-expressing liver cancer, we tried to prepare a vaccine by formulating recombinant HBsAg with BW006, a B type CpG oligodeoxynucleotide (ODN) with Th1-biasing activity, and examined its potency of inducing therapeutic immunity against HBsAg-expressing liver cancer cells in mice. When applied therapeutically, BW006 could assist HBsAg to induce vigorous immune responses capable of inhibiting the growth of HBsAg-expressing liver cancer cells and prolonging the survival of mice bearing HBsAg-expressing liver cancer cells. In vivo and in vitro experiments showed that the BW006-adjuvanted HBsAg enhanced the production of IgG2a antibodies, interferon-γ, and interleukin-12 and facilitated the generation of specific cytotoxic T lymphocyte that killed the HBsAg-expressing liver cancer cells. These results suggest that the BW006-adjuvanted HBsAg might be developed into a candidate tumor vaccine for the treatment of HBsAg-expressing liver cancer.
AuthorsXiaojing Zhou, Hongfei Wei, Peng Sun, Xiuli Wu, Min Wan, Peng Zhang, Sheng Guo, Tiesuo Zhao, Yongli Yu, Liying Wang
JournalCancer biotherapy & radiopharmaceuticals (Cancer Biother Radiopharm) Vol. 27 Issue 4 Pg. 234-42 (May 2012) ISSN: 1557-8852 [Electronic] United States
PMID22537404 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD69 antigen
  • Cancer Vaccines
  • Hepatitis B Surface Antigens
  • Immunoglobulin G
  • Lectins, C-Type
  • Oligodeoxyribonucleotides
  • Recombinant Proteins
  • Interleukin-12
  • Interferon-gamma
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, T-Lymphocyte (metabolism)
  • Cancer Vaccines (immunology, therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy, immunology)
  • Cell Proliferation
  • Female
  • Hepatitis B Surface Antigens (immunology)
  • Humans
  • Immunoglobulin G (metabolism)
  • Interferon-gamma (metabolism)
  • Interleukin-12 (metabolism)
  • Kaplan-Meier Estimate
  • Lectins, C-Type (metabolism)
  • Liver Neoplasms (drug therapy, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Transplantation
  • Oligodeoxyribonucleotides (immunology)
  • Recombinant Proteins
  • T-Lymphocytes, Cytotoxic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: